Investor Relations News

September 02, 2025

Evonik successfully issues green hybrid bond

  • Continued commitment to hybrid capital as a strategic element of financing structure
  •  Net proceeds primarily used to finance investments in Next Generation Solutions and Technologies   
  •  €500 million green hybrid bond with first redemption right in 2031 fits well into balanced maturity profile 

Not for publication, distribution or transmission in the United States of America, Canada, Australia or Japan.

Essen, Germany. Evonik Industries AG has successfully issued a green hybrid bond with a nominal volume of €500 million and a coupon of 4,25 %. The transaction, which marks the fourth consecutive green bond issuance of Evonik already, further underscores the company’s commitment to sustainable finance and a resilient capital structure.

The hybrid bond, with a formal lifetime of 30 years and a first redemption right in 2031, reflects Evonik’s strategic decision to retain hybrid capital as a permanent element of its financing structure. The issuance combined with a tender offer enables the early refinancing of the existing green hybrid bond with a first redemption right in 2026.

The hybrid bond benefits from Moody’s revised rating methodology, resulting in an investment-grade instrument rating of Baa3, which is only one notch below the company rating of Baa2 (positive outlook). S&P has assigned a BBB- instrument rating.

The issuance is aligned with Evonik’s Green Finance Framework, last updated in 2023, which is based on the ICMA Green Bond Principles. The framework has been externally verified through a Second Party Opinion by ISS, also issued in 2023, confirming its robustness and credibility in supporting sustainable investments.

“This transaction demonstrates our continued commitment to maintaining a solid investment grade rating and embedding sustainability into every aspect of our activities - including our financing strategy,” said Maike Schuh, Chief Financial Officer of Evonik.

Proceeds will be primarily used to finance Next Generation Solutions and Next Generation Technologies. Next Generation Solutions are products with a superior sustainability profile based on innovation in circularity, biosolutions and clean energy. Examples are skin-identical ceramides and other biofunctional actives for health and personal care, anion exchange membranes for green hydrogen production and omega-3 fatty acids sourced from microalgae as a renewable alternative to marine-based sources. Evonik plans to further increase the proportion of sales it generates from Next Generation Solutions by 2030 to 50 percent, from 45 percent in 2024.

At the same time, Evonik will further reduce its own ecological footprint. To this end, the company continuously invests in its processes along the entire value chain through its Next Generation Technologies resulting in projects like the climate-neutral production of alkoxides in Singapore.

The hybrid bond was significantly oversubscribed, attracting strong demand from institutional investors with a focus on sustainability.

BofA Securities acted as hybrid structuring agent and global coordinator. Barclays and ING served as global coordinators, with Commerzbank, Deutsche Bank, DZ Bank and LBBW as additional joint bookrunners.

Evonik: Leading beyond chemistry

Evonik goes beyond the boundaries of chemistry with its combination of innovative strength and leading technological expertise. The global chemical company, headquartered in Essen, Germany, is active in more than 100 countries and generated sales of €15.2 billion and earnings (adjusted EBITDA) of €2.1 billion in 2024. The common motivation of the approximately 32,000 employees: to provide customers with a decisive competitive advantage with tailor-made products and solutions as a superforce for industry, thereby improving people's lives. In all markets. Every day.

Disclaimer

This IR News constitutes neither an offer to sell nor a solicitation of an offer to buy securities. In particular, this document constitutes neither an offer to sell nor a solicitation of an offer to purchase securities in the United States. The securities of Evonik Industries AG described above (the "Securities") may not be offered or sold in the United States or to or for the account or benefit of "U.S. persons" (as such term is defined in Regulation S under the U. S. Securities Act of 1933, as amended (the "Securities Act")) absent registration or an exemption from registration under the Securities Act. The Securities have not been and will not be registered under the Securities Act or the securities laws of any State of the United States. There will be no public offering of the Securities in the United States.

In so far as forecasts or expectations are expressed in this release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.